Ashish V. Chintakuntlawar

Evidence of Molecular Evolution Driven by Recombination Events Influencing Tropism in a Novel Human Adenovirus that Causes Epidemic Keratoconjunctivitis

Michael P. Walsh, Ashish V. Chintakuntlawar, Christopher M. Robinson et al. · PLoS ONE · 2009 · 241 citations · Full text

Life Sciences, Infectious Diseases, Molecular Biology +14

Phase II Evaluation of Aggressive Dose De-Escalation for Adjuvant Chemoradiotherapy in Human Papillomavirus–Associated Oropharynx Squamous Cell Carcinoma

J. Daniel, Katharine A. Price, Eric J. Moore et al. · Journal of Clinical Oncology · 2019 · 226 citations · Full text

Medicine, Oncology, Radiation Oncology +11

Expression of PD-1 and PD-L1 in Anaplastic Thyroid Cancer Patients Treated With Multimodal Therapy: Results From a Retrospective Study

Ashish V. Chintakuntlawar, Kandelaria M. Rumilla, Carin Y. Smith et al. · The Journal of Clinical Endocrinology & Metabolism · 2017 · 135 citations · Full text

Medicine, Oncology, Radiation Oncology +17

Survival in Response to Multimodal Therapy in Anaplastic Thyroid Cancer

Naiyarat Prasongsook, Aditi Kumar, Ashish V. Chintakuntlawar et al. · The Journal of Clinical Endocrinology & Metabolism · 2017 · 126 citations · Full text

Medicine, Oncology, Palliative Medicine +12

Chemokine CXCL1/KC and its Receptor CXCR2 Are Responsible for Neutrophil Chemotaxis in Adenoviral Keratitis

Ashish V. Chintakuntlawar, James Chodosh · Journal of Interferon & Cytokine Research · 2009 · 85 citations · Full text

Medicine, Infectious Diseases, Ophthalmology +17